Member Info for WeTookPelham

Although not many overall, again, there more trades on Aquis, including a 150k late yesterday, not sure if sell or a buy?

Best wishes C7.

Seems the number of trades on aquis is marginally outnumbering the regular ones, again I think?

Also shows it's not quite as quiet as it appears on here.

....and thanks Bermuda for clarification.

Any significance possibly in releasing today's RNS just prior to ASCO?

Thanks Ruckrover RE Simon stage.

"... but it would add a huge , huge wedge of time ... get a deal done !! how many more years do they want shareholders to wait ??"

Agree, they really need to start pushing the commercial aspect and start doing the deals now IMO.

But who knows (except Scancell) that deals could be much closer than that, but they would not be able to discuss obviously.

Many thanks Botski and Bobbust.

A couple of questions if I may:

- Simon Stage 2? Can someone explain this please?

- "...Some interest in our lead antibody though preference is to take this into phase 1 as will 'add a zero to current antibody "deal'". Sorry, daft question, so that would be how much approximatley if based on this: https://www.lse.co.uk/rns/SCLP/signs-commercial-license-agreement-with-genmab-wsksutknedqtof9.html

- "And they are trying to increase publicity." Generally or to the bio world?

After the bell.

Anyone care to confirm if a buy?

Your buys appear to be showing on the Acquis exchange, along with a separate(?) 126k buy. Scinv I assume?

So are you a holder here then?

Maybe you should sell up if you're that worried? Assuming you have any shares to begin with.

@jambaion - agree with your interpretation.

Let's hope it's the start of a GenMab spending spree!

Wonder what that means RE their cancer vaccine platform? Based on the same technology, no?

Can't read the full article? What does it say?

But if you also can only read the same vague headline I can, then your interpretation of it RE Genmabs specific relationship with Scancell is more than a bit of a stretch. IMO.

Thanks TF, never really understood about the inner workings of a companies organisation.

I should have clarified, Sath taking on the company secretary role and replacing Keith Green. Should that not have been RNS'd?

But yes, some game changer news would be most welcome!

"…..many corporate mergers fail due to having too many executives for the post-merger number of executive chairs available. I don’t think that will be a problem with Scancell……"

So this sounds like a good thing i.e. a streamlined organisation? But why wasn't this RNS'd?

I've lost track how many conferences and more importantly how many presentations there have been this year already. Seems very different from previous years IMO.